An initial consultation with Dr Andrew Conn is from £216.
Dr Andrew Conn
Consultant Medical Oncologist
BMed Sci, BM BS, FRCP, PhD, PGDip
Specialises in
Also available for:
Virtual consultations:
I have been an NHS Consultant Medical Oncologist since 2007. I am an expert in the use of systemic anti-cancer therapy for the treatment of colon cancer, rectal cancer, lung cancer and mesothelioma. I have been caring for private patients for over 15 years.
I pride myself in providing my patients with the most effective care for their cancer. This is achieved through ensuring that each patient receives a personalised approach that guarantees access to the best Systemic Anti-Cancer Therapy. As important as delivering the best treatments, I prioritise supporting the emotional needs of my patients at all times.
All patients with a cancer illness should be able to benefit from the many advances in the treatments that are now available. Modern cancer care is based on a personalised approach through molecular profiling of an individual’s cancer.
This makes sure that each and every patient gets the most effective treatment for their cancer through the use of chemotherapy, immunotherapy, monoclonal antibodies and tyrosine kinase inhibitors.
Through my specialist interest in colon cancer, rectal cancer, lung cancer and mesothelioma all of the patients under my care can be confident that they will receive the best treatments and therefore the best outcomes. At Spire Leeds Hospital this will be further enhanced through support from a highly skilled team including a dietitian, psychologist, complimentary therapist, specialist nurse and chemotherapy nurses.
I take pride in offering each patient with bowel cancer, lung cancer or mesothelioma a personalised treatment plan that guarantees access to the most effective treatments. In addition to chemotherapy this also includes the use of targeted therapies such as Avastin (bevacizumab), Erbitux (cetuximab) and Zaltrap (aflibercept) in bowel cancer and Xalkori (crizotinib), Iressa (gefitinib) and Tarceva (erlotinib) in lung cancer. This commitment to an individualised approach to patient care ensures the best possible outcomes for my patients.
General Medical Council Number: 4309040
Treatment information
Some of the principal treatments carried out by Dr Andrew Conn at Spire include:
Other treatments
- Checkpoint inhibitors
- Immunotherapy
- Monoclonal antibodies
- Systemic Anti-Cancer Therapy (SACT)
- Tyrosine kinase inhibitors
Get in touch
Additional information
Clinical interests
Qualification and professional memberships
BMedSci / University of Nottingham, / 1994
, Bachelor of Medical Sciences (2:1
BMBS / University of Nottingham / 1996
Bachelor of Medicine and Surgery
PhD / University of Nottingham / 2004
Doctor of Philosophy
PGDip Oncol / University of Nottingham / 2006
Postgraduate Diploma in Oncology
Professional memberships
Member of Royal College of Physicians
Fellow of the Royal College of Physicians (England)
Member of the European Society for Medical Oncology
Member of the Association of Cancer Physicians
Professional leadership
I am the Specialty Lead for Medical Oncology at Bradford Teaching Hospitals NHS Foundation Trust.
I am the Acute Oncology Lead at Bradford Teaching Hospitals NHS Foundation Trust.
I am the Acute Oncology Lead for the North Sector, West Yorkshire Association of Acute Trusts.
Current NHS posts
Bradford Teaching Hospitals NHS Foundation Trust
Personal profile
I like to stay active through road cycling, mountain biking, running, going to the gym, walking and hiking. I enjoy visiting Liverpool where our daughter is studying medicine and trips to The Lake District with my wife. When I have time, I am trying to learn Spanish, but have to admit I am only making slow progress!
Contact information
| Telephone | 0113 218 5908/9 |
| Private secretary | Bev Timmins |
| Private secretary telephone | 01274 550 842 |
| Private secretary fax | 01274 550 769 |
| Private secretary email | beverly.timmons@nhs.net |